BioCentury
ARTICLE | Clinical News

Eniluracil: Interim Phase II data

December 17, 2012 8:00 AM UTC

Interim data from 122 evaluable patients who had previously been treated with an anthracycline and taxane in the open-label, international Phase II AHX-03-202 trial showed that once-weekly 40 mg oral ...